Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Taiko Pharmaceutical Revenue

Taiko Pharmaceutical had revenue of 916.00M JPY in the quarter ending March 31, 2026, a decrease of -20.35%. This brings the company's revenue in the last twelve months to 6.16B, up 1.62% year-over-year. In the year 2025, Taiko Pharmaceutical had annual revenue of 6.40B with 1.67% growth.

• Revenue (ttm): 6.16B
• Revenue Growth: +1.62%
• P/S Ratio: 2.09
• Revenue / Employee: 28.01M
• Employees: 220
• Market Cap: 12.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.40B	105.00M	1.67%
Dec 31, 2024	6.29B	172.00M	2.81%
Dec 31, 2023	6.12B	1.08B	21.43%
Dec 31, 2022	5.04B	-6.26B	-55.39%
Dec 31, 2021	11.30B	-11.16B	-49.68%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error